levodopa - medicine shortage information

Back to CRITICAL Shortages     Back to ALL Shortages

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.

In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19A"

Product details Supply Impact Dates Further Details
SINEMET CR levodopa/carbidopa 200 mg/50 mg modified release tablet bottle
AUST R: 171694
Active ingredients:
carbidopa monohydrate
levodopa

Sponsor:
Merck Sharp & Dohme (Australia) Pty Ltd

Phone:
1800 818 553

From
15 Jan 2019
to
15 Mar 2021

Status:
Current

Patient impact:
Critical

Availability:
Unavailable

Reason:
Other

TGA Management Actions:
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.